The Allstate Corporation
ALLLast close · Oct 16, 2026247.88+8.28 (+3.46%)
Market cap$62.7B
10 firms' latest targets, last 90 days: median $265.50 ($221.00–$315.00), 7% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-12 | Wells Fargo | $236.00 | ▼ 6% | -5% |
| 2026-10-07 | Mizuho Securities | $295.00 | ▼ 2% | +19% |
| 2026-10-07 | Barclays | $221.00 | ▼ 2% | -11% |
| 2026-10-07 | HSBC | $266.00 | ▲ 1% | +7% |
| 2026-10-01 | Goldman Sachs | $250.00 | ▼ 11% | +1% |
| 2026-08-28 | Argus Research | $238.00 | — | -4% |
| 2026-08-11 | Morgan Stanley | $265.00 | ▲ 10% | +7% |
| 2026-08-11 | Raymond James | $315.00 | ▲ 5% | +27% |
| 2026-08-10 | UBS | $275.00 | ▲ 5% | +11% |
| 2026-08-06 | Roth Capital | $300.00 | ▲ 9% | +21% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2021reported | $50.6B | +13% | $4.96 | -71% | est. $41.0B+23% | est. $13.47 | 1 |
| 2022reported | $51.4B | +2% | -$5.22 | -205% | est. $45.5B+13% | est. -$1.04 | 1 |
| 2023reported | $57.1B | +11% | -$1.20 | — | est. $49.9B+15% | est. -$1.17 | 3 |
| 2024reported | $64.1B | +12% | $16.99 | — | est. $55.2B+16% | est. $16.82 | 3 |
| 2025reported | $67.7B | +6% | $38.06 | +124% | est. $59.0B+15% | est. $30.46 | 5 |
| 2026 | $61.0B | -10% | $35.61 | +17% | $60.6B–$61.5B | $32.50–$38.06 | 5 |
| 2027 | $62.1B | +2% | $28.05 | -21% | $61.0B–$63.8B | $24.80–$33.41 | 5 |
| 2028 | $64.1B | +3% | $26.61 | -5% | $60.4B–$67.8B | $23.70–$28.76 | 7 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.